dianhydro-3,4-diacetylgalactitol and Emesis

dianhydro-3,4-diacetylgalactitol has been researched along with Emesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erdélyi-Tóth, V; Gyergyay, F; Hindy, I; Kanyár, B; Kerpel-Fronius, S; Kovács, P; Mechl, Z; Nekulová, M; Somfai-Relle, S; Ujj, G	1

Other Studies

1 other study(ies) available for dianhydro-3,4-diacetylgalactitol and Emesis

Article	Year
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG). Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:3 Topics: Adult; Aged; Antimetabolites; Antineoplastic Agents; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematopoietic Stem Cells; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Sugar Alcohols; Vomiting	1986

Article

Year

Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG).

Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:3

Topics: Adult; Aged; Antimetabolites; Antineoplastic Agents; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematopoietic Stem Cells; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Sugar Alcohols; Vomiting

1986